Sage Therapeutics Profit Margin

The latest profit margin for SAGE is -427.77% as of June 2025. That compares with -458.3% in the prior-year period — up 6.7% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Sage Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, SAGE's profit margin moved from -458.3% to -427.77% — a 6.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sage Therapeutics's valuation or profitability profile.

Against Healthcare companies, SAGE currently prints -427.77% for profit margin, while the sector average sits near 9.48%. That is roughly 4611.9% below the sector mean. Large gaps often invite a closer look at Sage Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Sage Therapeutics converts resources into returns. At -427.77%, SAGE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -458.3% in the prior-year period — up 6.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SAGE's profit margin (-427.77%), review year-over-year change from -458.3%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.